Covaxin 77.8% effective against Covid-19 in Lancet study

  • 3 years ago
Analysis data on the safety and efficacy of Bharat Biotech’s vaccine against Covid-19, Covaxin, following its Phase 3 clinical trials, has been peer-reviewed and published in the medical journal, The Lancet.

Recommended